Summit Therapeutics Inc.
SMMT· Nasdaq
Summit Therapeutics Inc.
- Last sale
- Oct 2, 2026 · +0.48%
- Market cap
- $13.37B
- 797.75M shares
- Filings
- 554
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2024 | 2024-12-31 | $0 | reported | |
| FY 2023 | 2023-12-31 | $0 | reported | |
| FY 2022 | 2022-12-31 | $705,000 | reported | |
| FY 2021 | 2021-12-31 | $1,809,000 | reported | |
| FY 2020 | 2020-12-31 | $860,000 | reported | |
| FY 2019 | 2019-12-31 | $743,000 | reported | |
| FY 2018 | 2019-01-31 | $57,088,000 | reported |
Summit Therapeutics Inc. · CIK 1599298 · Engraved from SEC EDGAR
